Organization
Skåne University Hospital, Lund, Sweden
1 abstract
Abstract
AN OPEN-LABEL STUDY TO EVALUATE BIOMARKERS AND SAFETY IN SYSTEMIC SCLEROSIS (SSC) PATIENTS TREATED WITH PAQUINIMOD (ABR-215757) Org: Skåne University Hospital, Lund, Sweden, University of Erlangen-Nuremberg, Erlangen, Germany, Charité Universitätsmedizin Berlin, Berlin, Germany, Active Biotech AB, Lund, Sweden, University Hospital Zurich, Zurich, Switzerland,